Additional Metadata
Persistent URL dx.doi.org/10.1016/j.urolonc.2019.02.007, hdl.handle.net/1765/116762
Journal Urologic Oncology
Citation
Verbeek, J.F.M., & Roobol-Bouts, M.J. (2019). Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore. Urologic Oncology, 37(6), 341–342. doi:10.1016/j.urolonc.2019.02.007